Lucid Diagnostics Inc. (LUCD) income statement
LUCDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/3025% above fair value
$0.37−0.01 (-3.52%)
Close on Nov 20, 2026Market cap $75.75MP/E –Yield –
Lucid Diagnostics Inc. financial ratios
See a number that looks wrong?